 | • レポートコード：MRC2210A0085 • 出版社/出版日：Transparency Market Research / 2022年7月 • レポート形態：英文、PDF、243ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、世界の光線力学的療法（PDT）市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別（光増感剤治療薬、装置）分析、用途別（がん、光線性角化症（AK）、乾癬、にきび、その他）分析、エンドユーザー別（病院、C&DC、CCC、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況など、以下の項目を掲載しております。本書では、Galderma Laboratories,L.P.、Biofrontera AG、Excel Lasers Limited、LUMIBIRD group（Quantel Medical）、Modulight Corporation、Quest PharmaTech,Inc.、Theralase Technologies,Inc.、SUS Advancing Technology Co.,Ltd.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の光線力学的療法（PDT）市場規模：製品種類別 - 光線力学的療法（PDT）光増感剤治療薬の市場規模 - 光線力学的療法（PDT）装置の市場規模 ・世界の光線力学的療法（PDT）市場規模：用途別 - がん治療用光線力学的療法（PDT）の市場規模 - 光線性角化症（AK）治療用光線力学的療法（PDT）の市場規模 - 乾癬治療用光線力学的療法（PDT）の市場規模 - にきび治療用光線力学的療法（PDT）の市場規模 - その他用途の市場規模 ・世界の光線力学的療法（PDT）市場規模：エンドユーザー別 - 病院における市場規模 - C&DCにおける市場規模 - CCCにおける市場規模 - その他エンドユーザーの市場規模 ・世界の光線力学的療法（PDT）市場規模：地域別 - 北米の光線力学的療法（PDT）市場規模 - ヨーロッパの光線力学的療法（PDT）市場規模 - アジア太平洋の光線力学的療法（PDT）市場規模 - 中南米の光線力学的療法（PDT）市場規模 - 中東/アフリカの光線力学的療法（PDT）市場規模 ・競争状況 |
Photodynamic Therapy Market – Scope of Report
TMR’s report on the global photodynamic therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global photodynamic therapy market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global photodynamic therapy market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the photodynamic therapy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global photodynamic therapy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global photodynamic therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global photodynamic therapy market.
The report delves into the competitive landscape of the global photodynamic therapy market. Key players operating in the global photodynamic therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global photodynamic therapy market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market photodynamic therapy.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Covid-19 Impact Analysis
6. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Photosensitizer Drugs
6.3.1.1. Porphyrin Derivative (PD)
6.3.1.1.1. Hematoporphyrin Derivative (HpD)
6.3.1.1.2. Benzoporphyrin Derivative (BPD)
6.3.1.1.3. Texaphyrins
6.3.1.1.4. Others
6.3.1.2. Aminolevulinic acid (ALA)
6.3.1.3. Chlorines
6.3.1.4. Others
6.3.2. Devices
6.3.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
6.3.2.2. Diode Laser
6.4. Market Attractiveness Analysis, by Product Type
7. Global Photodynamic Therapy Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Cancer
7.3.1.1. Basal Cell Carcinoma
7.3.1.2. Non-Small Cell Lung Cancer
7.3.1.3. Head & Neck Cancer
7.3.1.4. Others
7.3.2. Actinic Keratosis (AK)
7.3.3. Psoriasis
7.3.4. Acne
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Photodynamic Therapy Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. C&DC
8.3.3. CCC
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Photodynamic Therapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Photodynamic Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Photosensitizer Drugs
10.2.1.1. Porphyrin Derivative (PD)
10.2.1.1.1. Hematoporphyrin Derivative (HpD)
10.2.1.1.2. Benzoporphyrin Derivative (BPD)
10.2.1.1.3. Texaphyrins
10.2.1.1.4. Others
10.2.1.2. Aminolevulinic acid (ALA)
10.2.1.3. Chlorines
10.2.1.4. Others
10.2.2. Devices
10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
10.2.2.2. Diode Laser
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Cancer
10.3.1.1. Basal Cell Carcinoma
10.3.1.2. Non-Small Cell Lung Cancer
10.3.1.3. Head & Neck Cancer
10.3.1.4. Others
10.3.2. Actinic Keratosis (AK)
10.3.3. Psoriasis
10.3.4. Acne
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. C&DC
10.4.3. CCC
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Photosensitizer Drugs
11.2.1.1. Porphyrin Derivative (PD)
11.2.1.1.1. Hematoporphyrin Derivative (HpD)
11.2.1.1.2. Benzoporphyrin Derivative (BPD)
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulinic acid (ALA)
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
11.2.2.2. Diode Laser
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Cancer
11.3.1.1. Basal Cell Carcinoma
11.3.1.2. Non-Small Cell Lung Cancer
11.3.1.3. Head & Neck Cancer
11.3.1.4. Others
11.3.2. Actinic Keratosis (AK)
11.3.3. Psoriasis
11.3.4. Acne
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. C&DC
11.4.3. CCC
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Photosensitizer Drugs
12.2.1.1. Porphyrin Derivative (PD)
12.2.1.1.1. Hematoporphyrin Derivative (HpD)
12.2.1.1.2. Benzoporphyrin Derivative (BPD)
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulinic acid (ALA)
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
12.2.2.2. Diode Laser
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Cancer
12.3.1.1. Basal Cell Carcinoma
12.3.1.2. Non-Small Cell Lung Cancer
12.3.1.3. Head & Neck Cancer
12.3.1.4. Others
12.3.2. Actinic Keratosis (AK)
12.3.3. Psoriasis
12.3.4. Acne
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. C&DC
12.4.3. CCC
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Photosensitizer Drugs
13.2.1.1. Porphyrin Derivative (PD)
13.2.1.1.1. Hematoporphyrin Derivative (HpD)
13.2.1.1.2. Benzoporphyrin Derivative (BPD)
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulinic acid (ALA)
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
13.2.2.2. Diode Laser
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Cancer
13.3.1.1. Basal Cell Carcinoma
13.3.1.2. Non-Small Cell Lung Cancer
13.3.1.3. Head & Neck Cancer
13.3.1.4. Others
13.3.2. Actinic Keratosis (AK)
13.3.3. Psoriasis
13.3.4. Acne
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. C&DC
13.4.3. CCC
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Photosensitizer Drugs
14.2.1.1. Porphyrin Derivative (PD)
14.2.1.1.1. Hematoporphyrin Derivative (HpD)
14.2.1.1.2. Benzoporphyrin Derivative (BPD)
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulinic acid (ALA)
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
14.2.2.2. Diode Laser
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Cancer
14.3.1.1. Basal Cell Carcinoma
14.3.1.2. Non-Small Cell Lung Cancer
14.3.1.3. Head & Neck Cancer
14.3.1.4. Others
14.3.2. Actinic Keratosis (AK)
14.3.3. Psoriasis
14.3.4. Acne
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. C&DC
14.4.3. CCC
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Galderma Laboratories, L.P.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Biofrontera AG
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. 15.3.1.5. Recent Developments
15.3.3. Excel Lasers Limited
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. LUMIBIRD group (Quantel Medical)
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Modulight Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Quest PharmaTech, Inc.
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Theralase Technologies, Inc.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. SUS Advancing Technology Co., Ltd.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region , 2017–2031
Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type,2017–2031
Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices,2017–2031
Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drug, 2017–2031
Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031